Logotype for Chicago Atlantic Real Estate Finance Inc

Chicago Atlantic Real Estate Finance (REFI) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Chicago Atlantic Real Estate Finance Inc

Q2 2026 earnings summary

11 Aug, 2026

Executive summary

  • Delivered a productive Q2 2026 with net income of $7.47 million, down from $8.88 million in Q2 2025, as distributable earnings per share fell below the dividend due to capital redeployment timing and lower exit fees.

  • Announced a merger agreement with Chicago Atlantic BDC (LIEN), aiming to create a $771M+ portfolio BDC focused on cannabis and underserved markets, with closing expected in Q4 2026.

  • Closed a $62.5 million Koach Capital transaction, issuing 4.3 million shares for second lien notes secured by 32 cannabis-leased retail properties, diversifying revenue streams.

  • Portfolio performance remained strong despite earnings pressure from timing of repayments and deployments.

  • Focus remains on lending to state-licensed cannabis operators, leveraging a diversified portfolio across geographies and asset types.

Financial highlights

  • Loan portfolio principal totaled $453.1 million across 26 companies as of June 30, 2026, with a weighted average yield to maturity of 15.8%.

  • Gross originations were $59.2 million, offset by $19.7 million in repayments, including $16.4 million from full prepayments.

  • Net interest income for Q2 2026 was $12.83 million, down from $14.42 million in Q2 2025.

  • Distributable earnings per share were $0.44 (basic) and $0.43 (diluted); Q2 dividend was $0.47 per share.

  • Book value per share was $14.15 as of June 30, 2026; 21.7 million shares outstanding, rising to 26 million pro forma for Koach Capital transaction.

Outlook and guidance

  • Expectation to distribute 90%-100% of distributable earnings as dividends for the 2026 tax year; a special dividend may be issued in Q4 2026 if required.

  • Merger with LIEN anticipated to close in Q4 2026, subject to approvals, with transition to a BDC structure.

  • Conservative outlook maintained despite positive regulatory momentum; strategy does not depend on federal policy changes.

  • Regulatory reforms, including federal rescheduling of medical cannabis, anticipated to improve operator cash flows and increase lending opportunities.

  • No formal forward guidance on earnings or dividends was provided.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more